Overview

Phase I Study of the Combination of Irinotecan and POF (POFI)

Status:
Not yet recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The purpose of the phase I study is to establish the safety of Combination of Irinotecan and paclitaxel with 5-FU, leucovorin, oxaliplatin.
Phase:
Phase 1
Details
Lead Sponsor:
Fujian Cancer Hospital
Treatments:
Fluorouracil
Irinotecan
Leucovorin
Levoleucovorin
Oxaliplatin
Paclitaxel